Home / Share Price Target / Samratph
Samrat Pharmachem Share Price Target 2024, 2025, 2026 to 2039 With Charts
Samrat Pharmachem Limited | |||
Symbol: SAMRATPH | |||
Price: ₹469.35 | |||
Exchange: BSE | |||
-> |
Show Table of Contents
Table of Contents
- 0.1: Samrat Pharmachem Financial Performance
- 0.1.1: Is Samrat Pharmachem A Good Buy For Long Term?
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Samrat Pharmachem Share Price Target For 2024
- 1.1.1: Samrat Pharmachem Share Price Target Table For 2024
- 1.1.2: Summary: Samrat Pharmachem Share Price Prediction For 2024
- 1.2: Samrat Pharmachem Share Price Target For 2025
- 1.2.1: Samrat Pharmachem Share Price Target Table For 2025
- 1.2.2: Summary: Samrat Pharmachem Share Price Prediction For 2025
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Samrat Pharmachem Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 2.2: Samrat Pharmachem Share Price Target Table From 2024, 2025, 2026 to 2039
- 3: Samrat Pharmachem Past Performance
Advertisement
Samrat Pharmachem Financial Performance
Metric | Value | Description |
---|---|---|
Market Capital | 111.7 Crore | Market valuation of Samrat Pharmachem's shares. |
Revenue (TTM) | 310.64 Crore | Total revenue generated by Samrat Pharmachem over the past twelve months. |
Net Income (TTM) | +16.63 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
Operating Margin | 7.55% | Income from operations as a percentage of revenue, before taxes and interest. |
Profit Margin | 9.26% | Net income as a percentage of revenue, after all expenses. |
Revenue Growth (Quarterly) | -22.67% | Change in revenue compared to the previous quarter. |
Debt-to-Equity (D/E) Ratio | 0.31 | Company's total debt divided by total shareholder equity. |
Total Debt | 20.02 Crore | Sum of Samrat Pharmachem's current & long-term financial obligations. |
Total Cash | 4.93 Lakh | Total amount of liquid funds available to Samrat Pharmachem. |
Is Samrat Pharmachem A Good Buy For Long Term?
Samrat Pharmachem, with its small market cap and recent revenue dip, presents a moderate risk-to-reward ratio for long-term investment. While its profitability remains stable, the accumulated debt and low cash balance may raise concerns. Despite strong historical returns, the recent downtrend indicates market pressure. Investors seeking higher risk tolerance may consider the opportunity for potential growth, but cautious monitoring is advised given the company's current challenges.
To predict the Samrat Pharmachem's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Samrat Pharmachem Share Price Target For 2024
The line chart displays the monthly closing prices of Samrat Pharmachem with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Samrat Pharmachem shares in 2024, see the table below.
Advertisement
Samrat Pharmachem Share Price Target Table For 2024
Samrat Pharmachem's Levels | Value | Reason/Importance |
---|---|---|
2024 Target 3 | 485.00 (+3.33%) | Price Action: Oct 2024 High |
2024 Target 2 | 479.90 (+2.24%) | Price Action: Feb 2023 Low |
2024 Target 1 | 473.56 (+0.89%) | Custom Fibonacci Extension Lvl 23.6% |
Current Price | 469.35 | Samrat Pharmachem's 1 share price as of Thu 14 Nov 2024 |
Stop Loss 1 | 468.06 (-0.28%) | Price Action: Chart |
Stop Loss 2 | 462.50 (-1.46%) | Price Action: 13 Nov 2024 Low |
Stop Loss 3 | 457.86 (-2.45%) | Fibonacci Retracement Extended 40% |
Summary: Samrat Pharmachem Share Price Prediction For 2024
In summary, Samrat Pharmachem has surged by ₹121.15, achieving a notable +34.79% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Samrat Pharmachem for 2024 predicts an additional rise of 0.89% to 3.33% by the end of 2024 with three potential targets T1: 473.56, T2: 479.90, T3: 485.00. Stop Loss at SL1: 468.06, SL2: 462.50, SL3: 457.86.
Samrat Pharmachem has a 52-week high of ₹646.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹320.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Samrat Pharmachem.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Samrat Pharmachem Share Price Target For 2025
The line chart displays the monthly closing prices of Samrat Pharmachem with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Samrat Pharmachem shares in 2025, see the table below.
Advertisement
Samrat Pharmachem Share Price Target Table For 2025
Samrat Pharmachem's Levels | Value | Reason/Importance |
---|---|---|
2025 Target 3 | 683.08 (+45.53%) | Fibonacci Extension Level 123.6% |
2025 Target 2 | 666.59 (+42.02%) | Price Action: Chart |
2025 Target 1 | 659.99 (+40.61%) | Custom Fibonacci Extension Lvl 64.9% |
Current Price | 469.35 | Samrat Pharmachem's 1 share price as of Thu 14 Nov 2024 |
Stop Loss 1 | 425.00 (-9.45%) | Price Action: Feb 2024 High |
Stop Loss 2 | 420.00 (-10.52%) | Price Action: Jul 2022 Low |
Stop Loss 3 | 415.20 (-11.54%) | Price Action: Mar 2022 Low |
Summary: Samrat Pharmachem Share Price Prediction For 2025
In summary, Samrat Pharmachem has surged by ₹121.15, achieving a notable +34.79% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Samrat Pharmachem for 2025 predicts an additional rise of 40.61% to 45.53% by the end of 2025 with three potential targets T1: 659.99, T2: 666.59, T3: 683.08. Stop Loss at SL1: 425.00, SL2: 420.00, SL3: 415.20.
Samrat Pharmachem has a All-Time high of ₹1250.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹320.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Samrat Pharmachem, we have created a specific page for that check here: Samrat Pharmachem Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Samrat Pharmachem Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Samrat Pharmachem share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 13.13% over the next 15 years.
For complete year by year Samrat Pharmachem long term share price target from 2024, 2025 to 2039 check the below table.
Samrat Pharmachem Share Price Target Table From 2024, 2025, 2026 to 2039
Year | Samrat Pharmachem Target | YoY Change % |
---|---|---|
2024 | ₹469.35 | [Current Price] |
2024 | ₹472.39 | 0.64% |
2025 | ₹697.16 | 47.58% |
2026 | ₹861.04 | 23.5% |
2027 | ₹967.18 | 12.32% |
2028 | ₹1,090.83 | 12.78% |
2029 | ₹1,248.34 | 14.43% |
2030 | ₹1,559.15 | 24.89% |
2031 | ₹1,714.58 | 9.96% |
2032 | ₹1,767.31 | 3.07% |
2033 | ₹1,865.15 | 5.53% |
2034 | ₹2,024.31 | 8.53% |
2035 | ₹2,421.15 | 19.6% |
2036 | ₹2,568.12 | 6.07% |
2037 | ₹2,567.44 | -0.03% |
2038 | ₹2,639.47 | 2.8% |
2039 | ₹2,656.16 | 0.63% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Samrat Pharmachem Past Performance
- In 2002, Samrat Pharmachem opening price was ₹5
- As of Thu 14 Nov 2024 the price stands at ₹469.35.
- This represents a Compound Annual Growth Rate (CAGR) of 21.83%.
- In 22 years, an investment of 10,000 would have become ₹9.38 Lakh.
As we wrap up, we hope you like our study on Samrat Pharmachem share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Samrat Pharmachem Share Price History
- Samrat Pharmachem Price Target Tomorrow
- Samrat Pharmachem Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.